We are live on
!
Find out more
MM
MWG Management Portfolio holdings
AUM
$81.3M
1-Year Est. Return
2.28%
This Fund
S&P 500
This Quarter
Est. Return
+217.6%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
–
AUM
$158K
AUM Growth
–
Cap. Flow
+$100K
Cap. Flow
% of AUM
63.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beam Therapeutics
BEAM
|
+$89.7K |
| 2 |
Vir Biotechnology
VIR
|
+$10.6K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BCCM
BPC
AE
BHMP
LMKC
ASM
KDIA
CM
MWG Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for MWG Management, which disclosed 2 positions worth $158K. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Beam Therapeutics: 1,825 shares worth $149K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- MWG Management's largest Q4 2020 buy was Beam Therapeutics: 1,825 shares worth $149K.
- MWG Management's ten largest holdings make up 100% of its $158K portfolio in Q4 2020.
- MWG Management disclosed 2 positions in Q4 2020, its first 13F filing on record.
Based on MWG Management's 13F filing for Q4 2020, filed 17 Feb 2021.